Fresh Recalls

FDAClass II · Drug · Recall D-0500-2026 · Recalled May 6, 2026

iVIZIA recall — Thea Pharma, Inc.

Agency report date: May 6, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
iVIZIA
Company / brand
Thea Pharma
Lot / serial / date codes
Lot#: 3T36B, Exp. Date October 31, 2026.
Distribution
Nationwide within the United States
Agency product description and boundaries

iVIZIA, Sterile Lubricant Eye Drops (Povidone 0.5%), 0.33 Fl oz (10 mL), Made in France, Distributed by: Thea Pharma Inc., Waltham, MA 02451, NDC 82584-700-11

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: Lack of Assurance of Sterility: This recall has been initiated due to CGMP deviations found by the FDA during an inspection of the manufacturer.

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Class II: may cause temporary or medically reversible health consequences.

Affected product: iVIZIA recall status

3. Open the official notice or contact

Official recall ID
D-0500-2026
Brand
All Thea Pharma recalls
Classification
Class II
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Affected products

Companies & origin

Recalling firm location
Waltham, MA, United States
Firm address
303 Wyman St, 02451-1208

Identifying details (verbatim from the notice)

Product codes / lots
Lot#: 3T36B, Exp. Date October 31, 2026.
Distribution
Nationwide within the United States
Firm notified the public via
Letter
FDA event ID
98792
Recall initiated
April 23, 2026
FDA classified
April 28, 2026
FDA report date
May 6, 2026

Other drug recalls from around the same time

Verify with the official sources:

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked October 22, 2026 at 6:00 PM UTC. Record retrieved August 4, 2026 at 11:00 PM UTC.

Report a data error on this page